1. 128 SINGLE CENTER EXPERIENCE OF RIC BASED ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN 100 PATIENTS WITH MDS. Issue 1 (April 2015) Authors: Blaise, D.; Saillard, C.; Fürst, S.; Faucher, C.; Prebet, T.; El Cheikh, J.; Castagna, L.; Charbonnier, A.; Granata, A.; Rey, J.; Devillier, R.; Mohty, B.; Arnoulet, C.; Moziconnaci, M.J.; Chabannon, C.; Vey, N. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CHECKPOINT INHIBITION BEFORE HAPLOIDENTICAL TRANSPLANTATION IN RELAPSED OR REFRACTORY HODGKIN LYMPHOMA PATIENTS IS ASSOCIATED WITH HIGHER PFS WITHOUT INCREASED TOXICITIES. (12th June 2019) Authors: de Philippis, C.; Legrande, F.; Bramanti, S.; Montes de Oca, C.; Dulery, R.; Bouabdallah, R.; Granada, A.; Devillier, R.; Mariotti, J.; Sarina, B.; Harbi, S.; Maisano, V.; Furst, S.; Pagliardini, T.; Weiller, P.J.; Lemarie, C.; Calmels, B.; Chabannon, C.; Carlo‐Stella, C.; Santoro, A. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 298 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. IMPACT OF CLASS II HLA MISMATCH ON CLINICAL OUTCOMES IN HODGKIN LYMPHOMA PATIENTS RECEIVING HAPLOIDENTICAL STEM CELL TRANSPLANTATION (HAPLO‐SCT) WITH POST‐TRANSPLANT CYCLOPHOSPHAMIDE (PT‐CY). (12th June 2019) Authors: Castagna, L.; Bramanti, S.; Devillier, R.; Pagliardini, T.; Sarina, B.; Lemarie, C.; Furst, S.; Mariotti, J.; Granata, A.; de Philippis, C.; Harbi, S.; Legrand, F.; Maisano, V.; Bouabdallah, R.; Carlo‐Stella, C.; Calmels, B.; Chabannon, C.; Blaise, D.; Santoro, A. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 300 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P1329: POST-TRANSPLANT CYCLOPHOSPHAMIDE (PT-CY) VERSUS ANTITHYMOCYTE GLOBULIN (ATG) AS GVHD PROPHYLAXIS FOR MATCHED UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION. (23rd June 2022) Authors: Dachy, F.; Furst, S.; Calmels, B.; Pagliardini, T.; Harbi, S.; Bouchacourt, B.; Calleja, A.; Lemarie, C.; Collignon, A.; Morel, G.; Legrand, F.; Bekrieva, E.; Granata, A.; Weiller, P. J.; Chabannon, C.; Schiano de Collela, J. M.; Vey, N.; Blaise, D.; Devillier, R. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1214 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P1332: PROMISING OUTCOME OF PATIENTS OLDER THAN 70 YEARS WHO UNDERWENT PERIPHERAL BLOOD HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA OR HIGH RISK MYELODYSPLASTIC SYNDROME. (23rd June 2022) Authors: Harbi, S.; Brac de la perriere, L.; Garciaz, S.; Pagliardini, T.; Calmels, B.; Cecile, M.; Hicheri, Y.; Bouchacourt, B.; Calleja, A.; Dachy, F.; Fürst, S.; Lemarie, C.; Braticevic, C.; Morel, G.; Legrand, F.; Bekrieva, E.; Granata, A.; Weiller, P. J.; Chabannon, C.; Vey, N. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1217 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PB1810: OUTCOME OF ACUTE MYELOID LEUKEMIA RELAPSE AFTER ALLOGENIC STEM CELL TRANSPLANT: A SINGLE INSTITUTION RETROSPECTIVE STUDY. (23rd June 2022) Authors: Castoldi, C.; Hicheri, Y.; Devillier, R.; Hospital, M.-A.; D'Incan, E.; Garciaz, S.; Maisano, V.; Saillard, C.; Rey, J.; Granata, A.; Harbi, S.; Legrand, F.; Furst, S.; Blaise, D.; Vey, N. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1690 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗